Myths vs facts: ApoB and blood sugar

ApoB (Apolipoprotein B) is a measure of the number of atherogenic lipoproteins (LDL, VLDL) and a strong predictor of cardiovascular risk. A common myth is that ApoB directly affects blood sugar – this is incorrect. ApoB and blood sugar are linked via insulin resistance and metabolic syndrome, but there is no direct causal relationship. Elevated ApoB can occur in type 2 diabetes or prediabetes, but it is not a blood sugar marker. The evidence is mechanistic and epidemiological, not from randomized trials on glycemic control. Another myth: ApoB is only relevant for cholesterol. In fact, ApoB reflects the number of small, dense LDL particles, which are increased in insulin resistance. However, ApoB should not replace fasting glucose or HbA1c. Bottom line: ApoB is an important cardiovascular risk marker, but not a direct blood sugar indicator. If elevated, lifestyle changes and medical evaluation are warranted.